Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study - Archive ouverte HAL Access content directly
Journal Articles Pharmacoepidemiology and Drug Safety Year : 2015

Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study

(1, 2) , (1, 3) , (1) , (4, 5) , (1, 2)
1
2
3
4
5

Abstract

Purpose: There is still controversy on brand-to-generic (B-G) antiepileptic drugs (AEDs) substitution. Methods: To assess association between B-G AED substitution and seizure-related hospitalization, we designed a case crossover using the French National Health Insurance Database. We identified a cohort of adult patients who filled a prescription in 2009–2011 for AEDs with at least one brand name and one generic form. The outcome date was defined as the date of hospitalization, coded G40.x or G41.x, with a G40/G41 hospitalization-free period of at least 1 year. Patients with a medical history of cancer and women who gave birth in 2009–2011 were excluded. We required individuals to have regular dispensations of AEDs within the year preceding the outcome date. Free patients were defined as patients who had only brand name dispensations before the control period.Results: Eight thousand three hundred seventy nine patients (mean age ± standard deviation, 52.7 ± 18.8 years; sex ratio male/female, 1.27) were analyzed. Discordant pairs were 491 with B-G substitution in the control period only and 478 with B-G substitution in the case period only; odds ratio (95% confidence interval) 0.97 (0.86–1.10). No statistically significant interaction was detected among the four prespecified subgroup analyses (gender, age strata, free or non-free, and strict AED monotherapy or not). Controlling for non-seizure-related hospitalizations made no material difference. Sensitivity analyses yielded similar results.Conclusions: Brand-to-generic AED substitution was not associated with an elevated risk of seizure-related hospitalization.
Fichier principal
Vignette du fichier
Brand name to generic substitution of antiepileptic drugs_accepted.pdf (331.3 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01269917 , version 1 (02-05-2016)

Identifiers

Cite

Elisabeth Polard, Emmanuel Nowak, André Happe, Arnaud Biraben, Emmanuel Oger. Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study. Pharmacoepidemiology and Drug Safety, 2015, 24 (11), pp.1161-1169. ⟨10.1002/pds.3879⟩. ⟨hal-01269917⟩
311 View
413 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More